Physician
Psychiatry
Dr. Wayne Macfadden, MD
|
|
Give Review
Wayne Macfadden works in the field of Psychiatry. He graduated from University at Buffalo, School of Medicine and Biomedical Sciences. Wayne Macfadden is also a published doctor. He has 25 publication published. The most recent publication is: Effects of buprenorphine and naloxone in morphine-stabilized opioid addicts.
Publications
- Methodological approaches and magnitude of the clinical unmet need associated with amotivation in mood disorders.
- Adjunctive long-acting risperidone in patients with bipolar disorder who relapse frequently and have active mood symptoms.
- Health care resource utilization and costs in a commercially insured population of patients with bipolar disorder type I and frequent psychiatric interventions.
- Resource utilization in patients with schizophrenia who initiated risperidone long-acting therapy: results from the Schizophrenia Outcomes Utilization Relapse and Clin...
- Assessment of effectiveness measures in patients with schizophrenia initiated on risperidone long-acting therapy: the SOURCE study results.
- Effectiveness of injectable risperidone long-acting therapy for schizophrenia: data from the US, Spain, Australia, and Belgium.
- A Prospective Study Comparing the Long-term Effectiveness of Injectable Risperidone Long-acting Therapy and Oral Aripiprazole in Patients with Schizophrenia.
- Characteristics, healthcare utilization and costs of bipolar disorder type I patients with and without frequent psychiatric intervention in a Medicaid population.
- Clinical characteristics and resource utilization of patients with bipolar disorder who have frequent psychiatric interventions.
- Assessment of clinician awareness of nonadherence using a new structured rating scale.
- Risperidone long-acting therapy in stable patients with recently diagnosed schizophrenia.
- A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who r...
- A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholism.
- Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled ...
- Number needed to treat and time to response/remission for quetiapine monotherapy efficacy in acute bipolar depression: evidence from a large, randomized, placebo-contr...
- A randomized, double-blind, placebo-controlled study of quetiapine in the treatment of bipolar I and II depression: improvements in quality of life.
- Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).
- Quetiapine in the treatment of anxiety in patients with bipolar I or II depression: a secondary analysis from a randomized, double-blind, placebo-controlled study.
- A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression.
- Reply to article by Margolese and associates on tolerance and rebound during maintenance with quetiapine.
- Diabetes and atypical neuroleptics.
- [Lethal catatonia: clinical aspects and therapeutic intervention. A review of the literature].
- Effects of buprenorphine and naloxone in morphine-stabilized opioid addicts.
- Methadone and edema.
Schools
State University of New York At Buffalo
Doctors Specialties
- Addiction Psychiatry
- Psychiatry
Accepted Insurances
Education
-
University of Pennsylvania Health System -
University at Buffalo, School of Medicine and Biomedical Sciences
Helpful Reviews
Similar Doctors
|
|
Dr. Kenneth V. Master, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Haeng Ko, MD |
|
|
Dr. Jamie A. Mullen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alan N. Miller, MD |